These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16148181)

  • 21. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome.
    Murdaca G; Contini P; Setti M; Cagnati P; Villa R; Lantieri F; Indiveri F; Puppo F
    Hum Immunol; 2007 Nov; 68(11):894-900. PubMed ID: 18082568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of sildenafil citrate treatment on serum dehydroepiandrosterone sulfate levels in patients with erectile dysfunction.
    Tekdogan U; Tuncel A; Tuglu D; Basar MM; Atan A
    Urology; 2006 Sep; 68(3):626-30. PubMed ID: 16979704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
    Maillard A; Chapplain JM; Tribut O; Bentué-Ferrer D; Tattevin P; Arvieux C; Michelet C; Ruffault A
    J Clin Virol; 2007 Feb; 38(2):131-8. PubMed ID: 17208042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.
    Suy A; Castro P; Nomdedeu M; García F; López A; Fumero E; Gallart T; Lopalco L; Coll O; Gatell JM; Plana M
    J Infect Dis; 2007 Oct; 196(8):1191-201. PubMed ID: 17955438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi.
    Kumwenda JJ; Makanani B; Taulo F; Nkhoma C; Kafulafula G; Li Q; Kumwenda N; Taha TE
    Clin Infect Dis; 2008 Jun; 46(12):1913-20. PubMed ID: 18462100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
    Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
    J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommended dose for repair of serum vitamin A levels in patients with HIV infection/AIDS may be insufficient because of high urinary losses.
    Neves FF; Vannucchi H; Jordão AA; Figueiredo JF
    Nutrition; 2006 May; 22(5):483-9. PubMed ID: 16472980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
    Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ
    Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
    AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals.
    Li C; Collini P; Danso K; Owusu-Ofori S; Dompreh A; Candotti D; Opare-Sem O; Allain JP
    AIDS; 2006 Feb; 20(3):379-86. PubMed ID: 16439871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum dehydroepiandrosterone sulphate level in age-related macular degeneration.
    Tamer C; Oksuz H; Söğüt S
    Am J Ophthalmol; 2007 Feb; 143(2):212-216. PubMed ID: 17157799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.
    Lavreys L; Baeten JM; Chohan V; McClelland RS; Hassan WM; Richardson BA; Mandaliya K; Ndinya-Achola JO; Overbaugh J
    Clin Infect Dis; 2006 May; 42(9):1333-9. PubMed ID: 16586394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy.
    Sarmati L; Parisi SG; Nicastri E; d'Ettorre G; Palmisano L; Andreotti M; Andreoni C; Giuliano M; Gatti F; Boldrin C; Palù G; Vullo V; Vella S; Andreoni M
    J Clin Microbiol; 2005 Dec; 43(12):6183-5. PubMed ID: 16333125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different patterns of HIV-1 DNA after therapy discontinuation.
    Re MC; Vitone F; Sighinolfi L; Schiavone P; Ghinelli F; Gibellini D
    BMC Infect Dis; 2005 Sep; 5():69. PubMed ID: 16156892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient viremia in HIV-infected patients and use of plasma preparation tubes.
    Stosor V; Palella FJ; Berzins B; Till M; Leake A; Chmiel JS; Murphy RL
    Clin Infect Dis; 2005 Dec; 41(11):1671-4. PubMed ID: 16267742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of dehydroepiandrosterone sulfate (DHEAS) in ocular toxoplasmosis.
    de-la-Torre A; Ríos-Cadavid AC; Cardozo-García CM; Padilla L; Gómez-Marín JE
    J Microbiol Immunol Infect; 2012 Feb; 45(1):65-8. PubMed ID: 22153766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma testosterone and dehydroepiandrosterone sulfate in male and female patients with dysthymic disorder.
    Markianos M; Tripodianakis J; Sarantidis D; Hatzimanolis J
    J Affect Disord; 2007 Aug; 101(1-3):255-8. PubMed ID: 17182106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.